{"id":"https://openalex.org/W2117966469","doi":"https://doi.org/10.1586/erc.11.62","title":"Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study)","display_name":"Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study)","alternate_titles":[],"publication_year":2011,"publication_date":"2011-07-01","ids":{"openalex":"https://openalex.org/W2117966469","doi":"https://doi.org/10.1586/erc.11.62","mag":"2117966469","pmid":"https://pubmed.ncbi.nlm.nih.gov/21809964"},"language":"en","primary_location":{"id":"doi:10.1586/erc.11.62","doi":"https://doi.org/10.1586/erc.11.62","is_oa":false,"landing_page_url":"https://doi.org/10.1586/erc.11.62","pdf_url":null,"source":{"id":"https://openalex.org/S108504264","display_name":"Expert Review of Cardiovascular Therapy","issn_l":"1477-9072","issn":["1477-9072","1744-8344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Cardiovascular Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2117966469"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055245466","display_name":"Erica Romualdi","orcid":"https://orcid.org/0000-0002-6356-3631","observed_orcids":["https://orcid.org/0000-0002-6356-3631"]},"institutions":[{"id":"https://openalex.org/I115752224","display_name":"University of Insubria","ror":"https://ror.org/00s409261","country_code":"IT","type":"education","lineage":["https://openalex.org/I115752224"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Erica Romualdi","raw_affiliation_strings":["Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy","institution_ids":["https://openalex.org/I115752224"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102964045","display_name":"Marco Paolo Donadini","orcid":"https://orcid.org/0000-0001-5065-318X","observed_orcids":["https://orcid.org/0000-0001-5065-318X"]},"institutions":[{"id":"https://openalex.org/I115752224","display_name":"University of Insubria","ror":"https://ror.org/00s409261","country_code":"IT","type":"education","lineage":["https://openalex.org/I115752224"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marco P Donadini","raw_affiliation_strings":["Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy; Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy","University of Insubria, Varese, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy; Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy","institution_ids":["https://openalex.org/I115752224"]},{"raw_affiliation_string":"University of Insubria, Varese, Italy","institution_ids":["https://openalex.org/I115752224"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081041579","display_name":"Walter Ageno","orcid":"https://orcid.org/0000-0002-1922-8879","observed_orcids":["https://orcid.org/0000-0002-1922-8879"]},"institutions":[{"id":"https://openalex.org/I115752224","display_name":"University of Insubria","ror":"https://ror.org/00s409261","country_code":"IT","type":"education","lineage":["https://openalex.org/I115752224"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Walter Ageno","raw_affiliation_strings":["Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy; UO Medicina I, Ospedale di Circolo, Viale Borri 57, 21100 Varese, Italy; Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy; UO Medicina I, Ospedale di Circolo, Viale Borri 57, 21100 Varese, Italy","University of Insubria, Varese, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy; UO Medicina I, Ospedale di Circolo, Viale Borri 57, 21100 Varese, Italy; Research Centre on Thromboembolic Disorders and on Antithrombotic Therapies, Department of Clinical Medicine, University of Insubria, Varese, Italy; UO Medicina I, Ospedale di Circolo, Viale Borri 57, 21100 Varese, Italy","institution_ids":["https://openalex.org/I115752224"]},{"raw_affiliation_string":"University of Insubria, Varese, Italy","institution_ids":["https://openalex.org/I115752224"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I115752224"],"apc_list":null,"apc_paid":null,"fwci":16.4347,"has_fulltext":false,"cited_by_count":139,"citation_normalized_percentile":{"value":0.99060445,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"9","issue":"7","first_page":"841","last_page":"844"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":1.0},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9940000176429749},{"id":"https://openalex.org/keywords/recurrent-venous-thromboembolism","display_name":"recurrent venous thromboembolism","score":0.8360000252723694},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.8019999861717224},{"id":"https://openalex.org/keywords/factor-xa-inhibitors","display_name":"factor Xa inhibitors","score":0.8270000219345093},{"id":"https://openalex.org/keywords/oral-anticoagulation","display_name":"oral anticoagulation","score":0.7889999747276306},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.9160000085830688},{"id":"https://openalex.org/keywords/warfarin-alternatives","display_name":"warfarin alternatives","score":0.8970000147819519},{"id":"https://openalex.org/keywords/long-term-anticoagulation","display_name":"long-term anticoagulation","score":0.8069999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.983047604560852},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.9764411449432373},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.6294365525245667},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5778011083602905},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5585468411445618},{"id":"https://openalex.org/C2991741193","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thromboembolism","level":3,"score":0.5023183822631836},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4953862428665161},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.4865967035293579},{"id":"https://openalex.org/C2776413415","wikidata":"https://www.wikidata.org/wiki/Q17630273","display_name":"Idarucizumab","level":5,"score":0.4433749318122864},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3335704207420349},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32052111625671387},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.29617196321487427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29089096188545227},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.13178449869155884},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.1198708713054657},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0800686776638031},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006470","descriptor_name":"Hemorrhage","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054556","descriptor_name":"Venous Thromboembolism","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1586/erc.11.62","doi":"https://doi.org/10.1586/erc.11.62","is_oa":false,"landing_page_url":"https://doi.org/10.1586/erc.11.62","pdf_url":null,"source":{"id":"https://openalex.org/S108504264","display_name":"Expert Review of Cardiovascular Therapy","issn_l":"1477-9072","issn":["1477-9072","1744-8344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Cardiovascular Therapy","raw_type":"journal-article"},{"id":"pmid:21809964","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21809964","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of cardiovascular therapy","raw_type":"Journal Article"},{"id":"pmh:oai:irinsubria.uninsubria.it:11383/1729384","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11383/1729384","pdf_url":null,"source":{"id":"https://openalex.org/S4377196351","display_name":"IrInSubria (University of Insubria)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I115752224","host_organization_name":"University of Insubria","host_organization_lineage":["https://openalex.org/I115752224"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1955610473","https://openalex.org/W1969218311","https://openalex.org/W2011085863","https://openalex.org/W2011332991","https://openalex.org/W2028162842","https://openalex.org/W2028762958","https://openalex.org/W2045987573","https://openalex.org/W2059305858","https://openalex.org/W2064826963","https://openalex.org/W2074947904","https://openalex.org/W2075359369","https://openalex.org/W2085428181","https://openalex.org/W2087316845","https://openalex.org/W2102778065","https://openalex.org/W2110167268","https://openalex.org/W2111139930","https://openalex.org/W2115787552","https://openalex.org/W2156320702","https://openalex.org/W2158902152","https://openalex.org/W2169472792","https://openalex.org/W2551278876","https://openalex.org/W2568332688","https://openalex.org/W3021544616"],"related_works":["https://openalex.org/W2027408415","https://openalex.org/W2567185185","https://openalex.org/W2932612329","https://openalex.org/W2754231389","https://openalex.org/W2995175034","https://openalex.org/W2146332686","https://openalex.org/W2917920474","https://openalex.org/W2411435976","https://openalex.org/W2089621382","https://openalex.org/W2586912770"],"abstract_inverted_index":{"Over":[0],"recent":[1],"years,":[2],"research":[3],"on":[4],"anticoagulant":[5,40],"drugs":[6],"has":[7],"been":[8],"guided":[9],"by":[10],"the":[11,26,33,42,76,89,95,134],"requirement":[12],"for":[13,28,78,117,130],"convenient":[14],"administration":[15],"and":[16,142],"a":[17,36,98,112],"wide":[18],"therapeutic":[19],"window":[20],"to":[21,75,115],"allow":[22],"fixed":[23],"dosing":[24],"without":[25],"need":[27,77],"coagulation":[29],"monitoring.":[30],"Rivaroxaban":[31],"is":[32],"first":[34],"of":[35,39,46,84,91,97,123,147],"new":[37],"class":[38],"drugs,":[41],"direct,":[43],"selective":[44],"inhibitors":[45],"Factor":[47],"Xa.":[48],"The":[49],"EINSTEIN-extension":[50],"study":[51],"compared":[52],"rivaroxaban":[53,86,109],"with":[54,73,137],"placebo":[55],"in":[56,68,101,152],"patients":[57,118,136,141],"who":[58],"completed":[59],"their":[60],"standard":[61],"treatment":[62],"course":[63],"after":[64],"venous":[65],"thromboembolism":[66],"(VTE),":[67],"whom":[69,148],"there":[70],"was":[71],"equipoise":[72],"respect":[74],"continued":[79],"anticoagulation.":[80],"After":[81],"6-12":[82],"months":[83],"treatment,":[85],"significantly":[87],"reduced":[88],"risk":[90],"recurrent":[92],"VTE":[93],"at":[94],"cost":[96],"moderate":[99],"increase":[100],"bleeding":[102],"complications.":[103],"Overall,":[104],"these":[105],"results":[106],"suggest":[107],"that":[108],"can":[110],"be":[111],"valid":[113],"alternative":[114],"warfarin":[116],"requiring":[119],"long-term":[120],"secondary":[121],"prevention":[122],"VTE.":[124],"However,":[125],"additional":[126],"data":[127],"are":[128],"needed":[129],"special":[131],"populations":[132],"including":[133],"elderly,":[135],"cancer,":[138],"renally":[139],"impaired":[140],"morbidly":[143],"obese":[144],"patients,":[145],"all":[146],"were":[149],"scarcely":[150],"represented":[151],"this":[153],"trial.":[154]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2117966469","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":23},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
